Search Results - "Matevska, Nadica"

Refine Results
  1. 1

    Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients by Noveski, Predrag, Madjunkova, Svetlana, Sukarova Stefanovska, Emilija, Matevska Geshkovska, Nadica, Kuzmanovska, Maja, Dimovski, Aleksandar, Plaseska-Karanfilska, Dijana

    Published in PloS one (08-01-2016)
    “…Although age-related loss of chromosome Y (LOY) in normal hematopoietic cells is a well-known phenomenon, the phenotypic consequences of LOY have been elusive…”
    Get full text
    Journal Article
  2. 2

    The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors by Geskovski, Nikola, Matevska-Geshkovska, Nadica, Dimchevska Sazdovska, Simona, Glavas Dodov, Marija, Mladenovska, Kristina, Goracinova, Katerina

    Published in Beilstein journal of nanotechnology (29-04-2021)
    “…Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Review: Occult hepatitis C virus infection: Still remains a controversy by Dzekova Vidimliski, Pavlina, Nikolov, Igor, Matevska Geshkovska, Nadica, Dimovski, Aleksandar, Rostaing, Lionel, Sikole, Aleksandar

    Published in Journal of medical virology (01-09-2014)
    “…Occult hepatitis C virus (HCV) infection is characterized by the presence of HCV RNA in the liver cells or peripheral blood mononuclear cells of the patients…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The AKR1D136 ( rs1872930 ) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome by Kapedanovska-Nestorovska, Aleksandra, Dimovski, Aleksandar J, Sterjev, Zoran, Matevska Geskovska, Nadica, Suturkova, Ljubica, Ugurov, Petar, Mitrev, Zan, Rosalia, Rodney

    Published in Pharmacogenomics and personalized medicine (01-01-2019)
    “…The present observational cohort study evaluated the association between the (rs1872930) allele and the risk of major adverse cardiovascular and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Correlation of Somatic Mutations and Clinical Characteristics at Presentation in Patients with Essential Thrombocytemia by Eftimov, Aleksandar, Panovska-Stavridis, Irina, Popova-Simjanovska, Marija, Ivanovski, Martin, Stojanovic, Aleksandar, Cevreska, Lidija, Matevska, Nadica Geshkovska, Dimovski, Aleksandar J

    Published in Blood (06-12-2014)
    “…Background Most patients with essential thromocythemia (ET) have somatic mutations in janus kinase 2 (JAK2), calreticulin (CALR) and thrombopoietin receptor…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Frequency and Clinical Correlates of JAK2 46/1 Haplotype in Comparison with JAK2V617F Variant in Myeloproliferative Neoplasms: Single Center Experience by Panovska, Irina, Matevska, Nadica, Ivanovski, Martin, Trajkova, Sanja, Dukovski, Dusko, Cevreska, Lidija, Dimovski, Aleksandar

    Published in Blood (18-11-2011)
    “…Abstract 5173 It is predicted that the inherited genetic background in the individual patients with myeloproliferative neoplasm (MPN) influences the disease…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer by Hiljadnikova Bajro, Marija, Josifovski, Toni, Panovski, Milco, Jankulovski, Nikola, Kapedanovska Nestorovska, Aleksandra, Matevska, Nadica, Petrusevska, Natalija, Dimovski, Aleksandar J

    Published in Cancer genetics (01-04-2012)
    “…Uridine diphosphoglucuronate glucuronosyltransferase 1A1 (UGT1A1) is the key hepatic detoxification enzyme involved in the biotransformation of many…”
    Get full text
    Journal Article
  18. 18

    Variants of unknown significance (VUS) in patients with hereditary CRC without a known pathogenic variant by Stojovska, Marija, Matevska-Geshkovska, Nadica, Bozhinovikj, Elizabeta Krstevska, Grozdanovska, Biljana, Mitrevski, Nenad, Dimovski, Aleksandar

    Published in Journal of clinical oncology (01-06-2022)
    “…10599 Background: Nearly 5-10% of all newly diagnosed colorectal cancer (CRC) cases develop due to the presence of a highly penetrant pathogenic variant in one…”
    Get full text
    Journal Article
  19. 19

    Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction by Jenkins, Dagan, Caubit, Xavier, Dimovski, Aleksandar, Matevska, Nadica, Lye, Claire M., Cabuk, Feryal, Gucev, Zoran, Tasic, Velibor, Fasano, Laurent, Woolf, Adrian S.

    Published in Nephrology, dialysis, transplantation (01-01-2010)
    “…Background. Congenital pelvi-ureteric junction obstruction (PUJO) affects 0.3% of human births. It may result from aberrant smooth muscle development in the…”
    Get full text
    Journal Article
  20. 20

    Association between Gene Polymorphism of Manganese Superoxide Dismutase and Prostate Cancer Risk by Eken, Ayşe, Erdem, Onur, Arsova-Sarafinovska, Zorica, Akay, Cemal, Sayal, Ahmet, Matevska, Nadica, Suturkova, Ljubica, Erten, Koray, Özgök, Yaşar, Dimovski, Aleksandar, Aydin, Ahmet

    “…ABSTRACT Manganese superoxide dismutase (MnSOD) is the most effective antioxidant enzyme in mitochondria and protects cells from reactive oxygen…”
    Get full text
    Journal Article